Thursday, April 02, 2020 3:25:12 PM
May be.
But
My assumption is that psti wouldn’t easily expand the no. of patients treated
Without outside promoters. especially when there is home u.s company nominated.
(Except if they have definite results from the 3 in israel which is a very
Dangerous trial for the company since they where in dying situation)
therefore any assertive demand will help giving pluristem wide variety
Of patient’s situation to proof their s cells. (The note of Paul Knoepfler
contrary to vast amount of cell experts that support Msc sequence,
didn’t stop Cellularity from being appointed to do the trial.)
So Everyone here should help by writing/calling to the relevant
Factors with forceful demand to add all relevant companies to the trial.
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM